Beyond the Scope: The Promise and Limitations of Blood-Based Colorectal Cancer Screening.
作者信息
Dominitz Jason A
机构信息
Professor of Medicine University of Washington School of Medicine Seattle, Washington Executive Director, National Gastroenterology and Hepatology Program Director, National Colorectal Cancer Screening Program Veterans Health Administration Washington, DC.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):397-399.
Abstract
摘要
相似文献
1
Beyond the Scope: The Promise and Limitations of Blood-Based Colorectal Cancer Screening.范围之外：基于血液的结直肠癌筛查的前景与局限
Gastroenterol Hepatol (N Y). 2025 Jun;21(6):397-399.
2
Evaluation of a novel approach for colorectal cancer screening using an intelligent tool (INTEL-PATH CRC): a protocol for a multicentre, real-world, cohort study.使用智能工具（INTEL-PATH CRC）进行结直肠癌筛查的新方法评估：一项多中心、真实世界队列研究方案
BMJ Open. 2025 Jul 18;15(7):e098679. doi: 10.1136/bmjopen-2024-098679.
3
Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.无症状个体中，柔性乙状结肠镜检查与粪便潜血检测用于结直肠癌筛查的比较。
Cochrane Database Syst Rev. 2013 Oct 1;2013(9):CD009259. doi: 10.1002/14651858.CD009259.pub2.
4
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
5
Clinical Validation of a Circulating Tumor DNA-Based Blood Test to Screen for Colorectal Cancer.一种基于循环肿瘤DNA的血液检测用于筛查结直肠癌的临床验证
JAMA. 2025 Jun 2. doi: 10.1001/jama.2025.7515.
6
Screening for colorectal cancer using the faecal occult blood test, Hemoccult.使用便潜血试验（Hemoccult）筛查结直肠癌。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD001216. doi: 10.1002/14651858.CD001216.pub2.
7
Blood-Based Colorectal Cancer Screening: Implementation Into 2 Appalachian Primary Care Clinics.基于血液的结直肠癌筛查：在两家阿巴拉契亚初级保健诊所的实施情况。
Am J Prev Med. 2025 Jul;69(1):107636. doi: 10.1016/j.amepre.2025.04.006. Epub 2025 Apr 17.
8
National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence.沙特阿拉伯结直肠癌筛查国家指南，附推荐强度和证据质量说明。
Ann Saudi Med. 2015 May-Jun;35(3):189-95. doi: 10.5144/0256-4947.2015.189.
9
Cascade colorectal cancer screening guidelines: a global conceptual model.级联结直肠癌筛查指南：一个全球概念模型。
J Clin Gastroenterol. 2011 Apr;45(4):297-300. doi: 10.1097/MCG.0b013e3182098e07.
10
The Impact of Follow-up Colonoscopy on Survival in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program: A Nationwide Study.基于粪便免疫化学检测的结直肠癌筛查项目中结肠镜随访对生存的影响：一项全国性研究
Dis Colon Rectum. 2025 Jul 1;68(7):899-906. doi: 10.1097/DCR.0000000000003771. Epub 2025 Apr 9.
本文引用的文献
1
Can molecular cancer signals circulating in blood help us prevent cancer-related deaths?血液中循环的分子癌症信号能够帮助我们预防癌症相关死亡吗？
Lancet. 2025 Jan 6. doi: 10.1016/S0140-6736(24)02708-9.
2
Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer.新型基于血液或粪便的分子结直肠癌筛查检测的预期影响和成本效益
Ann Intern Med. 2024 Dec;177(12):1610-1620. doi: 10.7326/ANNALS-24-00910. Epub 2024 Oct 29.
3
Screening for Colorectal Cancer.结直肠癌筛查。
Ann Intern Med. 2024 Apr;177(4):ITC49-ITC64. doi: 10.7326/AITC202404160. Epub 2024 Apr 9.
4
Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy.基于血液生物标志物（液体活检）的结直肠癌筛查与粪便检测或结肠镜检查的比较有效性和成本效益。
Gastroenterology. 2024 Jul;167(2):378-391. doi: 10.1053/j.gastro.2024.03.011. Epub 2024 Mar 26.
5
Cell-free DNA for Colorectal Cancer Screening.用于结直肠癌筛查的游离DNA
N Engl J Med. 2024 Mar 14;390(11):1047-1050. doi: 10.1056/NEJMe2311101.
6
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.基于无细胞游离 DNA 的血液检测用于结直肠癌筛查。
N Engl J Med. 2024 Mar 14;390(11):973-983. doi: 10.1056/NEJMoa2304714.
7
Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence.综合卫生系统中基于血液的结直肠癌筛查：患者依从性的随机试验
Gut. 2024 Mar 7;73(4):622-628. doi: 10.1136/gutjnl-2023-330980.
Zotero 插件